KOA Biotech
Developer of on-site biosensing systems for aquaculture that combine microbiology techniques, consumable-based assays and machine learning to provide real-time pathogen monitoring, early detection of infections, and data-driven recommendations to reduce fish mortality and improve farm productivity.
Industries
Nr. of Employees
small (1-50)
KOA Biotech
Products
Intelligent biosensing device for real-time on-site pathogen detection
Autonomous biosensing instrument that integrates microbiological techniques with AI to perform in-facility pathogen monitoring using specialized consumables and deliver rapid results.
Autonomous biosensing device for early infection detection (coming soon)
Planned autonomous system that combines biosensing and machine learning to detect early-stage infections on-site and support outbreak prevention.
Intelligent biosensing device for real-time on-site pathogen detection
Autonomous biosensing instrument that integrates microbiological techniques with AI to perform in-facility pathogen monitoring using specialized consumables and deliver rapid results.
Autonomous biosensing device for early infection detection (coming soon)
Planned autonomous system that combines biosensing and machine learning to detect early-stage infections on-site and support outbreak prevention.
Services
Provision and installation of automated microbiological analysis devices at aquaculture facilities, followed by commissioning.
Web interface for real-time visualization of device outputs and facility metrics, enabling remote monitoring and data-driven decisions.
Provision and installation of automated microbiological analysis devices at aquaculture facilities, followed by commissioning.
Web interface for real-time visualization of device outputs and facility metrics, enabling remote monitoring and data-driven decisions.
Expertise Areas
- Pathogen detection for aquaculture
- Biosensing and diagnostic device development
- AI/ML for biological diagnostics
- Automated sample-to-answer workflows
Key Technologies
- Biosensing devices
- Machine learning for diagnostics
- Microbiological assays
- Consumable cartridge assays
News & Updates
The company is capitalized by INNVIERTE, the investment initiative of CDTI, E.P.E.
Reported monitoring hours on deployed systems (figures shown on site).
Publicly reported detection across dozens of pathogen types (figures shown on site).
The company is capitalized by INNVIERTE, the investment initiative of CDTI, E.P.E.
Reported monitoring hours on deployed systems (figures shown on site).
Publicly reported detection across dozens of pathogen types (figures shown on site).